Pneumocystis carini pneumonia is a major cause of death in AIDS patients in the United States. The presently available treatments have limited use due to a high incidence of adverse reactions. Therefore, there is an urgent need for a safer method for treatment and prevention of this disease. Recent evidence has suggested that P. carinn is related to fungi and that the wall ofthe cyst form contains 1,3-13-glucan as a major constituent. Based on this, several proposed 1,3-f3-glucan synthesis inhibitors were evaluated for their ability to control P. carinu pneumonia in vivo. Compounds from two classes of 1,3-13-glucan synthesis inhibitors, the echinocandins and papulacandins, were found to be effective against P. carinii.Pneumocystis carinii pneumonia is the most prevalent opportunistic infection and a frequent cause of death in AIDS
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.